Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2017 from OUS - Section for Cancer Cytogenetics
16 publications found
Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
Oncotarget, 8 (13), 21554-21560
DOI 10.18632/oncotarget.15795, PubMed 28423547
Recurrent fusion transcripts in squamous cell carcinomas of the vulva
Oncotarget, 8 (10), 16843-16850
DOI 10.18632/oncotarget.15167, PubMed 28186972
RNA-sequencing identifies novel GREB1-NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13)
Genes Chromosomes Cancer, 57 (4), 176-181
DOI 10.1002/gcc.22518, PubMed 29218853
Molecular characteristics of uterine sarcomas
Expert Rev Mol Diagn, 17 (5), 515-522
DOI 10.1080/14737159.2017.1311790, PubMed 28335657
ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity
Mod Pathol, 31 (4), 674-684
DOI 10.1038/modpathol.2017.162, PubMed 29192652
Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma
Genes Chromosomes Cancer, 56 (12), 841-845
DOI 10.1002/gcc.22485, PubMed 28758277
Loss of chromosome 13 material in cellular angiofibromas indicates pathogenetic similarity with spindle cell lipomas
Diagn Pathol, 12 (1), 17
DOI 10.1186/s13000-017-0607-6, PubMed 28193293
Genetic heterogeneity in leiomyomas of deep soft tissue
Oncotarget, 8 (30), 48769-48781
DOI 10.18632/oncotarget.17953, PubMed 28591699
Cytogenetic Analysis of a Pseudoangiomatous Pleomorphic/Spindle Cell Lipoma
Anticancer Res, 37 (5), 2219-2223
DOI 10.21873/anticanres.11557, PubMed 28476785
Karyotyping and analysis of GNAS locus in intramuscular myxomas
Oncotarget, 8 (13), 22086-22094
DOI 10.18632/oncotarget.14986, PubMed 28160572
Identification of SETD2-NF1 fusion gene in a pediatric spindle cell tumor with the chromosomal translocation t(3;17)(p21;q12)
Oncol Rep, 37 (6), 3181-3188
DOI 10.3892/or.2017.5628, PubMed 28498454
Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma
Oncotarget, 8 (61), 103775-103784
DOI 10.18632/oncotarget.21790, PubMed 29262599
FAM53B truncation caused by t(10;19)(q26;q13) chromosome translocation in acute lymphoblastic leukemia
Oncol Lett, 13 (4), 2216-2220
DOI 10.3892/ol.2017.5705, PubMed 28454383
DEK-NUP214-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15)
Cancer Genomics Proteomics, 14 (6), 437-443
DOI 10.21873/cgp.20053, PubMed 29109093
Involvement of DPP9 in gene fusions in serous ovarian carcinoma
BMC Cancer, 17 (1), 642
DOI 10.1186/s12885-017-3625-6, PubMed 28893231
Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene, SATB1, Resulting from a t(3;5)(p24;q14) Chromosomal Translocation in Acute Myeloid Leukemia
Anticancer Res, 37 (2), 693-698
DOI 10.21873/anticanres.11365, PubMed 28179318